中国学术期刊网络出版总库入编期刊
CNKI中文期刊全文数据库全文收录期刊
中国核心期刊(遴选)数据库全文收录期刊
万方数据——数字化期刊群收录期刊
中文科技期刊数据库全文收录期刊

主管:陕西省卫生健康委员会
主办:西安心身医学研究所
   西安交通大学第一附属医院
国际标准刊号:ISSN2096—1413
国内统一刊号:CN61—1503/R

喜炎平联合思密达治疗小儿腹泻效果评价

刘向婕

(陕西省府谷县中医医院儿科,陕西 榆林,719499)

浏览次数:164次 下载次数:406次

摘要:

目的 探讨喜炎平联合思密达治疗小儿腹泻的临床效果。方法 选择在我院治疗的198例小儿腹泻患儿作为研究对象, 随机分为对照组和观察组,对照组99例患儿给予思密达治疗,观察组99例患儿给予喜炎平联合思密达治疗。比较两组患儿治疗效果和不良反应发生情况。结果 对照组治疗有效率为90.8%,观察组治疗有效率为96.0%,两组比较,差异有统计学意义(P<0.05)。对照组和观察组不良反应发生率分别为8.1%和5.1%,两组比较,差异无统计学意义(P>0.05)。结论 小儿腹泻采用喜炎平联合思密达治疗效果显著,用药安全性高,值得临床推广应用。

关键词:喜炎平;思密达;小儿腹泻

中图分类号:R725.1文献标志码:A文章编号:2096-1413(2017)14-0093-02

    Effect evaluation of Xiyanping combined with Smecta in treatment of children with diarrhea
    LIU Xiang-jie
    (Department of Pediatrics, Fugu County Hospital of Traditional Chinese Medicine, Yulin 719499, China)

    ABSTRACT: Objective To investigate the clinical effect of Xiyanping combined with Smecta in treatment of children with diarrhea. Methods One hundred and ninety -eight cases of children with diarrhea in our hospital were selected as the research objects, and were randomly divided into control group and observation group. The control group (99 cases) were treated with smecta, while the observation group (99 cases) were treated with Xiyanping combined with Smecta. The treatment effect and adverse reaction between the two groups were compared. Results The effective rate of the control group was 90.8% , and the effective rate of the observation group was 96.0% , the difference between the two groups was statistically significant (P<0.05). The incidence of adverse reactions in the control group and observation group were 8.1% and 5.1% respectively, and there was no significant difference between the two groups (P>0.05). Conclusion Xiyanping
    combined with Smecta hasremarkable effect in the treatment of infantile diarrhea with high medication safety, which is worthy of clinical application.
    KEYWORDS: Xiyanping; Smecta; infantile diarrhea

    参考文献:
    [1] 许淑贞.喜炎平联合思密达治疗小儿腹泻疗效观察[J].求医问药:学术版,2012,10(7):539-540.
    [2] 吴敏,方国秀.喜炎平联合思密达治疗小儿腹泻50例临床观察[J].中国民族民间医药,2013,22(11):74.
    [3] 戴甩亲.喜炎平联合思密达治疗小儿腹泻疗效观察[J].大家健康(旬刊),2015,9(10):148-149.
    [4] 朱昭敏.联合使用喜炎平和思密达治疗小儿腹泻的疗效观察[J].当代医药论丛,2014,12(6):182-183.
    [5] 赵红玲.喜炎平、思密达、利巴韦林联合治疗小儿秋季腹泻疗效分析[J].中国现代药物应用,2013,7(2):76-77.
    [6] 王宇.喜炎平联合思密达治疗小儿腹泻疗效观察[J].中西医结合心血管病杂志:电子版,2015,36(2):90-91.
    [7] 王丹英.喜炎平联合思密达治疗小儿腹泻40例疗效观察[J].中医儿科杂志,2014,10(5):50-52.
    [8] 周汉明,赖伯存.喜炎平联合思密达治疗小儿腹泻疗效观察[J].河南医学研究,2016,25(1):97-98.
    [9] 刘霞,杨立帅.思密达联合喜炎平治疗40例小儿腹泻的临床观察[J].临床医药文献电子杂志,2015,2(7):1245-1246.
    [10] 王德兵.喜炎平与思密达联合治疗小儿腹泻的疗效观察[J].世界最新医学信息文摘,2015,15(76):67.

上一篇金双岐联合思密达治疗小儿腹泻的临床疗效及安全性分析

下一篇1,6二磷酸果糖及磷酸肌酸治疗儿童病毒性心肌炎的疗效分析